EBM

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Beilby, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Beilby, J.
Evidence-Based Medicine 2000; 5:170
© 2000 Evidence-Based Medicine

Weight loss in obese patients with asthma improved lung function and health status

Stenius-Aarniala B, Poussa T, Kvarnström J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000 Mar 25;320:827–32.[Abstract/Free Full Text]

QUESTION: In obese patients with asthma, does weight loss improve lung function and health status and alleviate symptoms?

Design
Randomised (allocation concealed*), unblinded,* controlled trial with 1 year follow up.

Setting
Outpatient clinic in Helsinki, Finland.

Patients
38 patients who were 18–60 years of age (mean age 49 y, 76% women), had a body mass index of 30 to 42, had asthma with a spontaneous diurnal variation or a bronchodilator response of >=15%, and were non-smokers. Exclusion criteria were pregnancy; history of bulimia or anorexia; other severe disease, including heart, thyroid, liver, or gallbladder disorders; insulin or systemic steroid treatment; or history of food allergy or intolerance to any element of the intervention diet. Follow up was complete.

Intervention
Patients were allocated to a weight loss group (n=19) or a control group (n=19). The weight reduction programme included 12 group therapy sessions in 14 weeks, including an 8 week dieting period in which patients took a very low energy dietary preparation (Nutrilett, Nycomed Pharma, Oslo, Norway) that provided 1760 kJ of . . . [Full text of this article]

Justin Beilby, MBBS, MD, MPH

University of Adelaide Adelaide, South Australia, Australia







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd.